Zicam Nasal Allclear swabs recalled nationwide for fungal contamination
Church & Dwight Inc. is recalling Zicam Nasal Allclear nasal swabs nationwide due to fungal contamination. All lots of the product are affected and consumers should discontinue use.
What this means for you
Highest-severity recall. Risk of serious injury or death is documented or strongly suspected. Stop using the product now and follow the agency's instructions.
Our severity reasoning: FDA Class I recalls are classified as Critical per the official severity rubric. This designation reflects the serious hazard posed by fungal contamination of nasal swabs intended for intranasal use.
Plain-English summary
Church & Dwight Inc. is recalling Zicam Nasal Allclear nasal swabs due to fungal contamination. The product is sold in cartons containing 20 single-use swabs. Approximately 13,632 cartons have been distributed nationwide across the United States, with all lot numbers included in the recall.
The recall was initiated due to the discovery of fungal contamination in the nasal swabs. The FDA has classified this as a Class I recall, indicating a serious hazard where contaminated product could cause adverse health effects.
Consumers should immediately stop using Zicam Nasal Allclear nasal swabs and discard any remaining product or return it to the place of purchase. Anyone who has used the product and experiences symptoms of adverse health effects should contact a healthcare provider. Additional questions about this recall can be directed to the FDA or Church & Dwight Inc.
The recalled product
- Product
- ZICAM NASAL ALLCLEAR, 20 Single-Use Swabs per carton, Distributed by Church & Dwight Co,. Inc.., Ewing NJ. UPC 7 32216 30165 6
- Manufacturer
- Church & Dwight Inc
- Category
- Drug — Nasal / OTC
- Hazard
- fungal-contamination
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All Lots.
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27